Edwards Lifesciences Corporatio vs Pfizer, Inc. — Stock Comparison

EW
Edwards Lifesciences Corporatio
$83.98
▲ 0.57%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Edwards Lifesciences Corporatio
EW7.2/10vs 6.5/10

Q·Score Breakdown

7.2
Bullish
Overall
6.5
Neutral
6.2
Quality
7.4
8
Health
7
7.3
Growth
5.6
7
Valuation
6.7
7.6
Sentiment
5.2
EW

Clean balance sheet with low leverage (0.1× debt-to-equity).

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

BUY
Target $97.15 (+15.7%)
27 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

EW
PFE
45.4×
Trailing P/E
19.4×
25.0×
Forward P/E
9.4×
17.4%
Profit Margin
12.4%
77.9%
Gross Margin
75.8%
ROE
8.9%
16.7%
Revenue Growth
-1.2%
8.2%
Earnings Growth
0.94
Beta
0.39
Price / Book
$48.4B
Market Cap
$149.8B
$72 – $88
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →